<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for Burmantofts, Harehills & Richmond Hill PCN</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for Burmantofts, Harehills & Richmond Hill PCN</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=pcn+U31228">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where Burmantofts, Harehills & Richmond Hill PCN is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=1002010M0&amp;denomIds=10.2.1&amp;selectedTab=summary">Neostigmine bromide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Drugs which enhance neuromuscular transmission</td>
      <td>30</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>17.76</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_xOGVWBh9gBcSo9Qr8cWQ8ICDxhsSuca2"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_xOGVWBh9gBcSo9Qr8cWQ8ICDxhsSuca2" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=1002010M0AAAAAA&amp;denomIds=10.2.1&amp;selectedTab=summary" target="_blank">Neostigmine 15mg tablets : 1</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0905022W0&amp;denomIds=9.5.2&amp;selectedTab=summary">Sucroferric oxyhydroxide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>30</td>
      <td>Phosphate binding agents</td>
      <td>156</td>
      <td>0.19</td>
      <td>0.00</td>
      <td>0.02</td>
      <td>9.26</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_edGLLhPRiwwhyJIiuhipZCORVCdEKzyV"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_edGLLhPRiwwhyJIiuhipZCORVCdEKzyV" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0905022W0AAAAAA&amp;denomIds=9.5.2&amp;selectedTab=summary" target="_blank">Sucroferric oxyhydroxide (iron 500mg) chewable tablets : 30</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0803042H0&amp;denomIds=8.3.4&amp;selectedTab=summary">Flutamide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>189</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.40</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_qhcSpkNgGYUUFT0YotQwkaE0pX1Acot"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_qhcSpkNgGYUUFT0YotQwkaE0pX1Acot" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0803042H0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Flutamide 250mg tablets : 3</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0206020M0&amp;denomIds=2.6.2&amp;selectedTab=summary">Nimodipine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Calcium-channel blockers</td>
      <td>20058</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.74</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_jGbelL7TqHPGxOWVb0TBLcZlxkSolsUJ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_jGbelL7TqHPGxOWVb0TBLcZlxkSolsUJ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0206020M0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Nimodipine 30mg tablets : 6</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0402010T0&amp;denomIds=4.2.1&amp;selectedTab=summary">Zuclopenthixol hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>307</td>
      <td>Antipsychotic drugs</td>
      <td>7809</td>
      <td>0.04</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>4.28</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_VAcvpcRLm6oUVgQVw03LVFSIqNiEqAER"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_VAcvpcRLm6oUVgQVw03LVFSIqNiEqAER" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAQ40lEQVR4nO3de9AkVX2H8ecsu8silwVvEeTSKhcFFURRJKEANQZshSiCBsELGo2FiRqtVAcvpcRLm6oUVgQVw03LVFSIqNiEqAERClC2EIEV5JK0KGjhBaFAlmWXzh99XneYbXd7d2a6Z973+VSdmpnTZ9/5zanhfb90n+4OVVUhSZK0MYv6LkCSJM0GQ4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKkVQ4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSVpfCFsTQhXb1n2Xo+lgaJAkSa0s7ruAcUmyIgDPBw4BtgaWxbYVdThaCawAfljm6f191SlJ0qwKVVX1XcNmi0FhP+A1sSUt/lkF3ARcA5wPXFzm6ZpJ1ShJM6k+JDH3P1jbUFUP9FmOpsPMhoYkK14HfBDYc6D7SuBrwN3AqoG2BbAv8DzgAGCXgX9zJ3A2cFaZpz+dfOWSNAMMDWowc6EhyYptgdOBE2LXNcCXgfPKPL2j5c/4E+BQ4ETgz4FAvQfiW0Be5ul3x1u1JM0YQ4MazFRoSLLiucCXgN2p9xC8rszTy0b8mU+hDg8nAjvF7q8D/1Dm6S2j/GxJmlmGBjWYidCQZMUi4F1ADiyh/qP+5jJPfzPG91gMHAN8HNgNWAN8GjhlnO8jSTPB0KAGUx8a4mLHc4HXAw8B7wE+XebpRApPsmIZ8E7gfcC2wO+ADPjcpN5TkqaOoUENZiE0fJh6weMdwCvKPL2+o/d9IvAh4K3UCykvBN5S5undXby/JPXK0KAGUx0akqx4PfB54D7goDJPV/ZQwwHAF6nP0rgbOLHM06LrOiSpU4YGNZja0JBkxaHUZzMsAo4o8/TbPdayNfAvwNti12eA95Z5+vu+apKkiTI0qMFUhoYkK54OXAVsD7y1zNN/67kkAJKsOBI4C3g8cANwVJmn/9dvVZI0AYYGNZi6e08kWfEEoKAODJ+YlsAAUObpN4BnAd+Jj9ckWXFYv1VJktSNqQoN8UyJ/wCeSn2J55P7rWh9ZZ7+EjgCOBV4HPDtJCtOirVLkjRvTVVoAN4IvBi4EXh9maeP9FtOszJP15R5+vfU9a4FTgPOSLJiaa+FSZI0QVOzpiGe4ngz9WGJg8o8vbrnklpJsuJA4ALgScDlwCu9GJSkmeeaBjWYpj0NpwI7AKfPSmAAiLU+j/q22wcDVyVZsXu/VUmSNH7TFBqOo76fxPv6LmRTlXl6J3AI9R029wCuTrLioH6rkiRpvKYpNACcVObpfX0XsTniNRtezboFkpckWfGafquSJGl8pmlNw3+WeXp033WMQ5IVJwH/Sh3K/pH61NHpmGhJasM1DWowTXsa/rbvAsalzNPTgaOA31PfNfNzSVYs6bcqSZJGMzV7GuajJCv2B74J7Eh9Sexjyzy9t9+qJKkF9zSowTTtaZh3yjy9FjiQ+pLTLwWuSLJi136rkiRp8xgaJqzM0zuAP6Pe0/BM6jMrnttvVZIkbTpDQwfiGSEvB86kPlRxeZIVx/dblSRJm8Y1DR2K96d4L5BTB7bTgPeUebq618IkaZhrGtTA0NCDJCteBHyZ+hbbVwHHxAtESdJ0MDSogYcnelDm6SXA/sAPgBcC1yZZcWivRUmStBHuaehRkhVbAp8E/gaoqK8m+YF4dUlJ6o97GtTA0DAFkqw4AfgUsBy4DTixzNPL+61K0oJmaFADQ8OUSLLiycAZQEq91+FTwMllnvofqqTuGRrUwNAwReLZFa+jvm/FDkAJvB/4Upmna3ssTdJCY2hQA0PDFEqy4knA6cCrYteN1LcMv9AbX0nqhKFBDQwNUyzJioOpb3j1p7HraurwcKnhQdJEGRrUwNAw5eIhi5cBHwX2jd03AJ8FvhivNilJ42VoUANDw4xIsmIRcCz1FSXn7l1xP/DvwGfLPL2ur9okzUOGBjUwNMygJCsOAN4O/BWwLHbfBJwHfKXM05V91SZpnjA0qIGhYYYlWbED8Abgjaw7dAHrAsRXgetd/yBpkxka1MDQME8kWbEncExsgwGiBL4OfA24oszTNd1XJ2nmGBrUwNAwD8UAcTRwFPCCgU2/BS6g3gtxSZmnD/dQnqRZYGhQA0PDPJdkxU7AK4C/BF4ELI2bfkt9+GIuQLgHQtI6hgY1MDQsIElWLAeOpD4L4y+AJXHTXcC5wNllnt7eT3WSpoqhQQ0MDQtUkhXbUweI44CXAiFu+i5wFnB+maer+qlOUu8MDWpgaBBJVuxKfQbGicBusftX1Jey/kyZp3f3VJqkvhga1MDQoD+IF5B6MfA24JXAIuAh4AvAqWWe3tRjeZK6ZGhQA0ODGiVZ8RTgncCbgW1i9zeAfyrzdEVvhUnqhqFBDQwN2qC49uEt1AFi59h9EXBKmaff760wSZNlaFADQ4NaSbJiS+qrT57MunUP3wI+XObplb0VJmkyDA1qYGjQJkmyYglwAvUtup8au/+Hes/D93orTNJ4GRrUwNCgzRLDw3HA+4HdY/dlwCnApd7vQppxhgY1MDRoJElWLAZeA3wA2Ct2X0EdHr5jeJBmlKFBDQwNGoskK7agvlnWB4C9Y/fV1OHhYsODNGMMDWpgaNBYxWs9vAr4IPCs2L0C+AhwYZmnj/RVm6RNYGhQA0ODJiKGhyOpw8NzYvetwCeBz5d56i8gaZoZGtTA0KCJSrIiACnwXuCQ2H0PcAZwWpmnd/ZVm6QNMDSogaFBnUmyYn/g3cBrgcXAWqAAzgT+y9tzS1PE0KAGhgZ1LsmKJwPvoL5E9RNi9y+Ac4Bzyjy9ra/aJEWGBjUwNKg3SVYsBV5OfZnqw1l3e+4VwFeA88o8LfupTlrgDA1qYGjQVEiyYhfgTcDxwB4Dm74PnAd8E7jFUzeljhga1MDQoKkSF04+m/qCUccCTxvY/L/UayAuAi4r8/TB7iuUFghDgxoYGjS1YoDYHziK+gyM/Qc2rwKuBC6N7ZoyT1d3XqQ0Xxka1MDQoJmRZMWO1GsfUuAlwPKBzb+nvnz1ldRXovxBmaf3dF6kNF8YGtTA0KCZFC9bvR9wWGwHA9sODbuZOkBcFR9Xlnm6tss6pZllaFADQ4PmhXjjrP2AA2N7Ietu3T3nfuAa6gCxArgW+KmLK6UGhgY1MDRo3kqy4onAC1gXJJ4PbDM07B7gh9QBYq7d6j0ytOAZGtTA0KAFIx7S2Ic6SOwf277AlkND7weu49FB4iavWKkFxdCgBoYGLWhJViwBnk59U625IPEc1t8jsQq4gUcHiRvLPF3VXbVShwwNamBokIbEO3TuzroAMRcmHjs0dA2wkjpAXAdcD/zIszY0Lxga1MDQILUQrxmxK+sCxFyg2LFh+M+IAWLg8VbP3NBMMTSogaFBGkG8dsTc2ohnx8c9gUVDQ1cBN8Z2M/CT+Hh7macPd1aw1JahQQ0MDdKYJVnxGGBv6gAxGCa2bxi+hvry2INB4ifALcCvPR1UvTE0qIGhQepAPLyxC3WYeDqw18Bj0yEOqK9yWQI/HWh3Ud9G/K7Yfmew0EQYGtTA0CD1LMmK7ajDw2CQ2APYjea9E4MeAn4D/Do+zrX7gQeog8cDDW2uf3VsDw+11cAaA8kCZmhQA0ODNMWSrFhOHR4S6oWYOwI7DT0+lvXXUIzLGtYPE00BY7hvY2MfBO4bavcOP3e9R48MDWpgaJBmXDxFdDnwuIG2NfCY+DjYhvuWAkuG2nBf05iurOLRYWIwXNzb8vn9XuFzMxga1MDQIGmTxPUZi9m8sDHXtxWwXWzLN/J8OaMFlYpHB465QzeDralvY/2r5vXhG0ODGhgaJE29JCuW0Rwmhp9vaNvwXVBHVVEHiAep15Y8RL1n5KFNeL0aeGSgVUOvN9RfDfRXDa2pf2Nj/3AYaa9flYv+++x3XAZwzHGf2PeaXfa5l3WHmOYOM632+iMLi6FB0oIQD+NsS31YZhvWP3Qz2Da2fXDMsthCd59m8rZavYqbTn01AM949/k8uHTZHxv6CAMhYuj5w9TrYtYAaweer9lI/9rYwgYaG9keqNf6zLWNvd6cMXPmwtfg80193XpsmacH05PFfb2xJHUprmuYW+8wVgOHbLaMbdkfeT78eint/lBt6A9YGHo+/EezTd9c/+JY05Ilj6zZCngVwBbV2ksGt8XHpudze4S6XPeiDk3FnoYQwkqAqqr26buWhcD57o5z3R3nujvOdXemba4ndZqWJEmaZwwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKmVqTjlUpIkTT/3NEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSplU5CQwjh0BDCyhDCbSGEM0MIWzSMOTaEcEsI4fYQwkcH+rcLIVwYQrg1hLAihPCMLmqeVSPO9REhhOtCCGtCCMd3W/nsGXGu/zmEcHMI4UchhG+HEHbrtvrZMuJcnxRCuD5+t1eEEA7ptvrZMspcD2w/MISw1t8jGzbi9/pDIYRfxO/1dSGE93VSdFVVE23UweQ2YO/4+ivAG4bGLAfuAHakvmf7lcAhcdtHgI/F5y8DLp10zbPaxjDXuwPPBL4AHN/355nmNoa5PhxYEp+/Hbig7880rW0Mc73dwLj9gLLvzzStbdS5jtuXAt8DCn+PTG6ugQ8B7++67i72NBwA3FVV1Y/j67OAo4fGHA58t6qqX1RVtQb4/MCYo4EzAaqqugjYM4TwuMmXPZNGmuuqqm6rqupG4JGuCp5ho871xVVVPRzHfR/YtYOaZ9Woc33fwLitAa9o98eN+vsa4GTgXOBXE6511o1jrjvXRWjYGfjZwOs7gF02Yczwtp/HPq1v1LlWe+Oc67cBF421uvll5LkOIbwphHALcCFwwoTqnA9GmusQwj7AQcA5E6xxvhjH75C3xkNvF4QQ9phMmY/WRWgIYxqjjXOuuzOWuQ4h/DXwHOBjI1c0f40811VVnVNV1Z7A8cApY6lqftrsuQ4hLAI+DfxdFfefa4NG/V5/FnhaVVXPBr5EHYgnrovQ8DMenYx2pd5b0HbMz4e27QzcOeYa54tR51rtjTzXIYSjgXcBaVVVD06ozvlgbN/reIjzWSGEHcZd5DwxylxvC+wDXBxCKIFXA6eGEE6cWLWzbaTvdVVVv5w7xFlV1ZeB7bs4dN9FaFgB7BxC2Du+fjPw1aExFwOHhRB2DCEsBt4wMOarwFsAQggvA26rqurXky97Jo0612pvpLkOIbwEyIEjqqry2O+GjTrXe80NCiEcDDxUVdU9ky97Jm32XFdVdW9VVY+vqiqpqioBzgfeXVXV2V0VP2NG/V7vNDcohHAY8DDw24lX3dEq0RcBPwZuB86mXgV6JHDmwJjXArfGMR8fWj36zbjtWmCfrleLzlIbca5fTJ1iH6D+8v0c2LLvzzStbcS5vpV6j9l1sX2n788zzW3EuT4NWBnn+Qrg+X1/nmluo8z10M85F8+emNhcU5/ldkP8Xl8OHNBFzd4aW5IkteIVISVJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa38PwnUDs3Xt/+sAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0402010T0AAAAAA&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Zuclopenthixol 2mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0402010T0AAABAB&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Zuclopenthixol 10mg tablets : 185</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0402010T0AAACAC&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Zuclopenthixol 25mg tablets : 107</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0402010T0BBABAB&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Clopixol 10mg tablets : 6</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where Burmantofts, Harehills & Richmond Hill PCN is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=1002010Q0&amp;denomIds=10.2.1&amp;selectedTab=summary">Pyridostigmine bromide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>29</td>
      <td>Drugs which enhance neuromuscular transmission</td>
      <td>30</td>
      <td>0.97</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-8.53</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_QmJETeaFSEzETLglBAshqRJEakKTSpAh"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_QmJETeaFSEzETLglBAshqRJEakKTSpAh" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=1002010Q0AAABAB&amp;denomIds=10.2.1&amp;selectedTab=summary" target="_blank">Pyridostigmine bromide 60mg tablets : 29</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501110C0&amp;denomIds=5.1.11&amp;selectedTab=summary">Metronidazole</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>263</td>
      <td>Metronidazole, tinidazole and ornidazole</td>
      <td>264</td>
      <td>1.00</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-3.19</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_eqH0oiLSXggGCURLUYMoRJGugkprwQqi"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_eqH0oiLSXggGCURLUYMoRJGugkprwQqi" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501110C0AAAEAE&amp;denomIds=5.1.11&amp;selectedTab=summary" target="_blank">Metronidazole 200mg/5ml oral suspension : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501110C0AAAIAI&amp;denomIds=5.1.11&amp;selectedTab=summary" target="_blank">Metronidazole 200mg tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501110C0AAAJAJ&amp;denomIds=5.1.11&amp;selectedTab=summary" target="_blank">Metronidazole 400mg tablets : 251</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501110C0AABHBH&amp;denomIds=5.1.11&amp;selectedTab=summary" target="_blank">Metronidazole 500mg tablets : 5</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501080W0&amp;denomIds=5.1.8&amp;selectedTab=summary">Trimethoprim</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>367</td>
      <td>Sulfonamides and trimethoprim</td>
      <td>559</td>
      <td>0.66</td>
      <td>0.87</td>
      <td>0.07</td>
      <td>-3.17</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_Hh9FywEEXEaRiLJECMimljAaRAUR0SEh"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_Hh9FywEEXEaRiLJECMimljAaRAUR0SEh" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501080W0AAADAD&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 100mg tablets : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501080W0AAAEAE&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 200mg tablets : 132</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0501080W0AAAIAI&amp;denomIds=5.1.8&amp;selectedTab=summary" target="_blank">Trimethoprim 50mg/5ml oral suspension sugar free : 147</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>13548</td>
      <td>Vitamin D</td>
      <td>14624</td>
      <td>0.93</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.75</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_SgQs0QRkMaIoYVMCiIoUIiAiImJkV0YR"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_SgQs0QRkMaIoYVMCiIoUIiAiImJkV0YR" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 1628</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 433</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 178</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 93</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABMBM&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 603</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 784</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 73</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 66</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACLCL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 123</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 146</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACUCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 84</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 40</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 688</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADVDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADXDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AADZDZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 30,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 388</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 31</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEPEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 78</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 499</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 109</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 2160</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 151</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 850</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 1388</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 502</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BRACCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 500mg/400unit caplets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 79</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 32</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 130</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 232</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 127</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CGABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 3,200unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 95</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CNADCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 40,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CPAACW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kalcipos-D 500mg/800unit tablets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CVAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 20,000unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0CYAADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">HealthAid Vitamin D3 200units/drop oral drops : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 999</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0DNAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 800unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0ECAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=0906040G0ECANEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 25,000unit capsules : 1</a></li></ul></td></tr><tr class="low_number row_5">
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=091101000&amp;denomIds=9.11.1&amp;selectedTab=summary">Other amino acidandnutritional agent preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Amino acids and nutritional agents</td>
      <td>4</td>
      <td>0.50</td>
      <td>0.96</td>
      <td>0.17</td>
      <td>-2.68</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_CESK7UEr4YfoSG0tXdukstbsqKLraQ5"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_CESK7UEr4YfoSG0tXdukstbsqKLraQ5" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U31228&amp;numIds=091101000BBUBA0&amp;denomIds=9.11.1&amp;selectedTab=summary" target="_blank">ProSource liquid 30ml sachets (4 flavours) : 2</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>